Your browser doesn't support javascript.
loading
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Liu, Yafei; Soh, Wai Tuck; Kishikawa, Jun-Ichi; Hirose, Mika; Nakayama, Emi E; Li, Songling; Sasai, Miwa; Suzuki, Tatsuya; Tada, Asa; Arakawa, Akemi; Matsuoka, Sumiko; Akamatsu, Kanako; Matsuda, Makoto; Ono, Chikako; Torii, Shiho; Kishida, Kazuki; Jin, Hui; Nakai, Wataru; Arase, Noriko; Nakagawa, Atsushi; Matsumoto, Maki; Nakazaki, Yukoh; Shindo, Yasuhiro; Kohyama, Masako; Tomii, Keisuke; Ohmura, Koichiro; Ohshima, Shiro; Okamoto, Toru; Yamamoto, Masahiro; Nakagami, Hironori; Matsuura, Yoshiharu; Nakagawa, Atsushi; Kato, Takayuki; Okada, Masato; Standley, Daron M; Shioda, Tatsuo; Arase, Hisashi.
Afiliação
  • Liu Y; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Soh WT; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Kishikawa JI; Laboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Hirose M; Laboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Nakayama EE; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Li S; Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Sasai M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Suzuki T; Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Tada A; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Arakawa A; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Matsuoka S; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Akamatsu K; Department Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Matsuda M; Department Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory for Supramolecular Crystallography, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Ono C; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Torii S; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Kishida K; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Jin H; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Nakai W; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Arase N; Department of Dermatology, Graduate school of Medicine, Osaka University, Osaka 565-0871, Japan.
  • Nakagawa A; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo 650-0047, Japan.
  • Matsumoto M; Drug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, Japan.
  • Nakazaki Y; Drug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, Japan.
  • Shindo Y; Drug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, Japan.
  • Kohyama M; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan.
  • Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo 650-0047, Japan.
  • Ohmura K; Department of Rheumatology, Kobe City Medical Center General Hospital, Hyogo 650-0047, Japan.
  • Ohshima S; Department of Clinical Research, Osaka Minami Medical Center, Kawachinagano, Osaka 586-8521, Japan.
  • Okamoto T; Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Yamamoto M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Nakagami H; Department of Health Development and Medicine, Graduate school of Medicine, Osaka University, Osaka 565-0871, Japan.
  • Matsuura Y; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Nakagawa A; Laboratory for Supramolecular Crystallography, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Kato T; Laboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Okada M; Department Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Standley DM; Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Shioda T; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Arase H; Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Rese
Cell ; 184(13): 3452-3466.e18, 2021 06 24.
Article em En | MEDLINE | ID: mdl-34139176
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article